Mohammed Makkawi

4PUBLICATIONS
11CO-AUTHORS
Tumour immunologyBiomolecular modelling and designMolecular targetsInformation systems for sustainable development and the public good
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 24, 2024
C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation.

Mesfer Al Shahrani, Reem M Gahtani, Mohammed Makkawi

|Oct 03, 2023
Identification by molecular dynamic simulation and in vitro validation of SISB-A1, N-[1-(4-bromophenyl)-3-methyl-1H-pyrazol-5-yl]-2-[(2-oxo-4-phenyl-2H-chromen-7-yl) oxy], as an inhibitor of the AblT315I mutant kinase to combat imatinib resistance in chronic myeloid leukemia.

Mesfer Al Shahrani, Reem M Gahtani, Mohammad Abohassan

|Jul 02, 2023
Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.

Hassan Hussain Almasoudi, Mohammed Ageeli Hakami, Abdulfattah Y Alhazmi

|Apr 28, 2022
Prediction Model of Adverse Effects on Liver Functions of COVID-19 ICU Patients.

Aisha Mashraqi, Hanan Halawani, Turki Alelyani

Pageof 1

Frequent Collaborators

2 joint publications

Mutaib Mashraqi

2 joint publications

Sultan Alasmari

1 joint publications

Aisha Mashraqi

1 joint publications

Hanan Halawani